TEL-AVIV, Israel and RALEIGH, N.C. - RedHill Biopharma Ltd. (NASDAQ: NASDAQ:RDHL), a specialty biopharmaceutical company with a market capitalization of $7.53 million, today announced the initiation ...
One in ten people in the UK have a needle phobia so serious it means they frequently miss out on vital treatments such as ...
3hon MSN
One in nine people in India is expected to to face a cancer diagnosis during their lifetime, says Dr. Vinayak V Maka, Senior ...
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback